ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch
AktivUID / MWST
CHE-209.784.395 MWST
Handelsregister-Nummer
CH-440-1038220-9
Sitz
Kreuzlingen
Zweck
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.
Management
AI-generated contentWerden Sie Beta-Tester
Wir entwickeln die Plattform aktiv weiter. Melden Sie sich für den Beta-Zugang an, um exklusiven frühen Zugriff auf neue Funktionen zu erhalten.
Publikationen
22.05.2024
25.03.2022
Frequently Asked Questions
What is the legal status of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is Aktiv in the Swiss Commercial Register.
What is the UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
The UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is CHE-209.784.395.
Where is ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch located?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is located in Kreuzlingen with its registered address at Eichhornweg 1, 8280 Kreuzlingen.
What is the legal form of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is registered as a Einzelunternehmen (EIU) in Switzerland.
What is the purpose of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.